--- title: "BlossomHill Therapeutics (BLSM) news: going concern and IPO" url: "https://aibio.space/companies/blossomhill-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BLSM going concern and IPO news: BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total. BlossomHill Therapeutics, Inc." --- BLSM BlossomHill Therapeutics, Inc. NASDAQ · United States # BlossomHill Therapeutics (BLSM) news BLSM going concern and IPO news Financings · 2026-08-07 ## [BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/) BlossomHill priced 9,375,000 shares at $16.00 for $150,000,000 before costs, with delivery expected on or about August 10, 2026. The auditor's report on the 2025 financial statements includes a going-concern paragraph. ## Latest BlossomHill Therapeutics news 1. 2026-07-17 Financings [BlossomHill Therapeutics files for IPO, plans Nasdaq listing as BLSM](https://aibio.space/news/blossomhill-therapeutics-files-ipo-plans-nasdaq-listing-blsm/) BlossomHill's S-1 leaves the share count, the price range and the proceeds blank. The prospectus also says the auditor's report on the 2025 financial statements carries a going-concern paragraph. ## BlossomHill Therapeutics at a glance - **Ticker**: BLSM - **Listing**: NASDAQ - **Country**: United States ### Related companies - [Retension Pharmaceuticals](https://aibio.space/companies/retension-pharmaceuticals/) NASDAQ: RTSN - [Soligenix](https://aibio.space/companies/soligenix/) NASDAQ: SNGX - [ABVC BioPharma](https://aibio.space/companies/abvc-biopharma/) NASDAQ: ABVC - [Atossa Therapeutics](https://aibio.space/companies/atossa-therapeutics/) NASDAQ: ATOS - [NOVACCESS GLOBAL INC.](https://aibio.space/companies/novaccess-global/) OTC: XSNX - [Nektar Therapeutics](https://aibio.space/companies/nektar-therapeutics/) NASDAQ: NKTR - [Arcutis Biotherapeutics](https://aibio.space/companies/arcutis-biotherapeutics/) NASDAQ: ARQT - [Zymeworks](https://aibio.space/companies/zymeworks/) NASDAQ: ZYME ### Also on NASDAQ - [Edgewise Therapeutics](https://aibio.space/companies/edgewise-therapeutics/) EWTX - [NEUROONE MEDICAL TECHNOLOGIES](https://aibio.space/companies/neuroone-medical-technologies/) NMTC - [Celldex Therapeutics](https://aibio.space/companies/celldex-therapeutics/) CLDX - [Aktis Oncology](https://aibio.space/companies/aktis-oncology/) AKTS - [Verastem](https://aibio.space/companies/verastem/) VSTM - [Cryoport](https://aibio.space/companies/cryoport/) CYRX ## Questions about BlossomHill Therapeutics Has BlossomHill Therapeutics issued a going-concern warning? Our latest story on this, dated Aug 7, 2026: "BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). When did BlossomHill Therapeutics go public? Our latest story on this, dated Aug 7, 2026: "BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). What is the ticker symbol of BlossomHill Therapeutics? BlossomHill Therapeutics, Inc. trades under the ticker BLSM on NASDAQ. Where is BlossomHill Therapeutics listed? BlossomHill Therapeutics, Inc. is listed on NASDAQ. What is the SEC CIK of BlossomHill Therapeutics? The SEC Central Index Key (CIK) for BlossomHill Therapeutics, Inc. is 1839970. Its filings are on SEC EDGAR. How many shares does BlossomHill Therapeutics have outstanding? 31,784,909 shares as of 2026-09-16, per the cover page of its 10-Q filed 2026-09-18. Which country or territory is BlossomHill Therapeutics listed under? Our directory records BlossomHill Therapeutics, Inc. under United States. What does BlossomHill Therapeutics do? Our directory classifies BlossomHill Therapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of BlossomHill Therapeutics? The ISIN recorded for BlossomHill Therapeutics, Inc. is US0951301003. Does aibio.space cover BlossomHill Therapeutics? aibio.space lists BlossomHill Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is BlossomHill Therapeutics incorporated? SEC records list its state or country of incorporation as DE. What is the latest BlossomHill Therapeutics (BLSM) stock news? Our latest story on BlossomHill Therapeutics, dated Aug 7, 2026: "BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total". BlossomHill priced 9,375,000 shares at $16.00 for $150,000,000 before costs, with delivery expected on or about August 10, 2026. The auditor's report on the 2025 financial statements includes a going-concern paragraph. [Source](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). What is BlossomHill Therapeutics's latest stock offering or financing news? Our latest financing story, dated Aug 7, 2026: "BlossomHill prices IPO of 9,375,000 shares at $16.00, $150,000,000 in total". BlossomHill priced 9,375,000 shares at $16.00 for $150,000,000 before costs, with delivery expected on or about August 10, 2026. The auditor's report on the 2025 financial statements includes a going-concern paragraph. [Source](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). Who were the underwriters or placement agents on BlossomHill Therapeutics's offering? From our story: The cover names J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital and H.C. Wainwright & Co. The prospectus names J.P. Morgan Securities LLC as an underwriter that will run the directed share program, through which shares are sold at the company's direction to directors, officers and certain others. [Source](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). How long will BlossomHill Therapeutics's cash last? From our story of Aug 7, 2026: The auditor's report on the 2025 financial statements includes a going-concern paragraph. [Source](https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/). ## Investor discussion: BlossomHill Therapeutics Members talk about BlossomHill Therapeutics (BLSM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at BlossomHill Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-08-07 Financings Reported a financing. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1839970/000119312526340215/d98958d424b4.htm) 2. 2026-07-17 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1839970/000119312526306506/d98958ds1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:BLSM on TradingView](https://www.tradingview.com/symbols/NASDAQ-BLSM/). ## SEC filings and registration - **SEC name**: BlossomHill Therapeutics, Inc. - **CIK**: 1839970 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: BLSM (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company
Emerging growth company - **Business address**: 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CA - **Phone**: 858-732-3880 - **Shares outstanding**: 31,784,909 as of 2026-09-16 (10-Q filed 2026-09-18) ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/1839970/000119312526395043/blsm-20260630.htm) filed 2026-09-18 - [8-K](https://www.sec.gov/Archives/edgar/data/1839970/000119312526395031/d266261d8k.htm) filed 2026-09-18 - [8-K](https://www.sec.gov/Archives/edgar/data/1839970/000119312526391328/d168153d8k.htm) filed 2026-09-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1839970/000119312526342316/d138762d8k.htm) filed 2026-08-10 - [S-1](https://www.sec.gov/Archives/edgar/data/1839970/000119312526306506/d98958ds1.htm) filed 2026-07-17 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839970), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details BlossomHill Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BLSM, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: BlossomHill Therapeutics, Inc. - **Ticker**: BLSM - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US0951301003 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-BLSM/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/blossomhill-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "BlossomHill Therapeutics (BLSM) news: going concern and IPO", 2026-10-31, https://aibio.space/companies/blossomhill-therapeutics/